Gabapentin for Chronic Neuropathic Pain.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 29486015.
- Also identified by DOI 10.1001/jama.2017.21547.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Is gabapentin associated with pain relief in people with chronic neuropathic pain? Oral gabapentin (1200-3600 mg/d for 4-12 weeks) for patients with moderate or severe neuropathic pain from postherpetic neuralgia (PHN) or painful diabetic neuropathy (PDN) is associated with pain reduction of at least 50% in 14% to 17% more patients than placebo.
Medical subject headings
- Amines
- Analgesics
- Cyclohexanecarboxylic Acids
- Diabetic Neuropathies
- Neuralgia, Postherpetic
- gamma-Aminobutyric Acid